Researchers track best next steps for advanced liver cancer after immunotherapy
NCT ID NCT06117891
First seen Nov 12, 2025 · Last updated May 15, 2026 · Updated 29 times
Summary
This study watches 300 adults with advanced liver cancer that can't be removed by surgery. All have already received a first-line immunotherapy combination (like atezolizumab plus bevacizumab). Researchers will collect data from routine doctor visits to see how well different second-line treatments work, including how long patients live and how long their cancer stays under control. No extra tests or visits are needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Corporal Michael J Crescenz Department Of Veterans Affairs Medical Center
Philadelphia, Pennsylvania, 19104, United States
-
Einstein Medical Center
Philadelphia, Pennsylvania, 19141, United States
-
Many Locations
Multiple Locations, Argentina
-
Many Locations
Multiple Locations, Brazil
-
Many Locations
Multiple Locations, China
-
Many Locations
Multiple Locations, Colombia
-
Many Locations
Multiple Locations, France
-
Many Locations
Multiple Locations, Greece
-
Many Locations
Multiple Locations, Italy
-
Many Locations
Multiple Locations, South Korea
-
Many Locations
Multiple Locations, Spain
-
Many Locations
Multiple Locations, Taiwan
-
Many Locations
Multiple Locations, Thailand
-
Mercy Medical Center - Medline Healthcare Services LLC
Baltimore, Maryland, 21202, United States
-
Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14203, United States
-
University Of Cincinnati Division Of Hematology Oncology - UC Health System
Cincinnati, Ohio, 45219, United States
-
University of Michigan Health System
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.